W STRATEGIES, LLC

Lobbying for ABBVIE INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $50,000.00 income · posted Jul 18, 2025

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Health Issues

Education and legislation related to reform of the 340(b) program.

Medicare/Medicaid

Medicare Implementation of the Inflation Reduction Act. H.R.1 - One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.